Market Study Report LLC

At 8.5% CAGR, Biodefense Market Size Set to Register 1390 Million USD by 2024 - Emergent Biosolutions, Hytest, GSK, Sanofi, PharmAthene

The newly released research at Market Study Report titled “2019-2024 Global Biodefense Market Report” provides data, information, brief analysis, company profiles, statistics for past years and forecasts for next few years.


Selbyville, DE -- (SBWIRE) -- 02/26/2019 -- According to this study, over the next five years the Biodefense market will register a 8.5% CAGR in terms of revenue, the global market size will reach US$ 1390 million by 2024, from US$ 850 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Biodefense business, shared in Chapter 3.

Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.

Request a sample of this premium report on Biodefense market at:

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3. Emergent Biosolutions, Hytest, GSK, Sanofi, PharmAthene, Bavarian Nordic, SIGA Technologies, Arbutus Biopharma, DynPort Vaccine, Xoma Corporation

In the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the country?s preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies. Since 2004, the US government has provided assistance in the development and manufacturing of products in order to maintain its Strategic National Stockpile (SNS) to counter any bioterror attack.
USA is still the largest supplier and consumption market due to the highly developed pharmaceuticals technology and increased awareness of the threat of global terror activity. In 2015, USA enjoyed over 80% consumption market.

By type, Anthrax defense products are most used with market share over 40%, followed by Smallpox defense products and Botulism defense products separately with market share about 30% and 14%. In addition, other diseases like Ebola and Marburg are occupying more and more market share.

In this year, the international situation is not complex, and partial conflict is frequent. Terrorist organization like IS was just making terrorist activity in Paris, which largely increased people?s awareness of the threat of terrorist activity. As a result, the biodefense industry is expecting in the next years.
Request a discount on standard prices of this premium report at:

Biodefense Market Report – Quick Rundown:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.

- Anthrax
- Smallpox
- Botulism
- Radiation/Nuclear
- Others

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.

- US Military Market
- US Civilian Market
- Non - US Market

With an objective to help understand the development plans and policies, manufacturing processes, cost structures of Biodefense market, this report lists and profiles leading players with top level information on them. Wherever applicable, it also focuses on the details like supply chain, market statistics, product images, development plan outlook, consumption (where available), growth rates, contact details and much more.

Sub-segments of the Biodefense market are expansively analyzed covering industry dynamics, help on a feasibility study, vendor strategies, growth prospects and market share of the industry. Growth projections for next few years form an important aspect of this 2018 Biodefense report.

Apart from whatever is already offered in this Biodefense market research, the report can be customized to meet your needs – be it additional company coverage or country coverage or anything specific that you need.

More Details on this Report At:

Table OF Content:

2019-2024 Global Biodefense Consumption Market Report

1 Scope of the Report

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview
2.1.1 Global Biodefense Consumption 2014-2024
2.1.2 Biodefense Consumption CAGR by Region
2.2 Biodefense Segment by Type
2.2.1 Soybean
2.2.2 Tempeh
2.2.3 Others
2.3 Biodefense Consumption by Type
2.3.1 Global Biodefense Consumption Market Share by Type (2014-2019)
2.3.2 Global Biodefense Revenue and Market Share by Type (2014-2019)
2.3.3 Global Biodefense Sale Price by Type (2014-2019)
2.4 Biodefense Segment by Application
2.4.1 Vegetarian
2.4.2 Non-vegetarian
2.5 Biodefense Consumption by Application
2.5.1 Global Biodefense Consumption Market Share by Application (2014-2019)
2.5.2 Global Biodefense Value and Market Share by Application (2014-2019)
2.5.3 Global Biodefense Sale Price by Application (2014-2019)

3 Global Biodefense by Players

3.1 Global Biodefense Sales Market Share by Players
3.1.1 Global Biodefense Sales by Players (2017-2019)
3.1.2 Global Biodefense Sales Market Share by Players (2017-2019)
3.2 Global Biodefense Revenue Market Share by Players
3.2.1 Global Biodefense Revenue by Players (2017-2019)
3.2.2 Global Biodefense Revenue Market Share by Players (2017-2019)
3.3 Global Biodefense Sale Price by Players
3.4 Global Biodefense Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Biodefense Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Biodefense Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Biodefense by Regions

4.1 Biodefense by Regions
4.1.1 Global Biodefense Consumption by Regions
4.1.2 Global Biodefense Value by Regions
4.2 Americas Biodefense Consumption Growth
4.3 APAC Biodefense Consumption Growth
4.4 Europe Biodefense Consumption Growth
4.5 Middle East & Africa Biodefense Consumption Growth

Related Report:

Biodefense Market Size By Product (Vaccines {Anthrax, Smallpox, Botulism}, Biothreat Detection Devices {Samplers, Detectors/Triggering Devices, Identifiers, Assays And Reagents}), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE), Application Potential, Competitive Market Share & Forecast, 2018 - 2024

Germany biodefense market was valued at USD 711.8 million in 2017. Government adopts certain initiatives to create awareness regarding the spread of endemic diseases due to deliberate release of microbes and viruses. Moreover, the regulatory bodies are involved in developing quality assurance program to maintain the standard of the biothreat devices that positively influences the industry growth.

About Market Study Report allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150